U.S. pharma large copyright scrapped two experimental weight loss capsules very last 12 months—a once-every day capsule, lotiglipron, because of elevated liver enzymes and a twice-daily tablet, danuglipron, because of potent side effects—but CEO Albert Bourla has said the company is determined to “Participate in and earn” within the being o